Skip to main content
. 2020 Feb 3;10:931. doi: 10.3389/fendo.2019.00931

Figure 1.

Figure 1

Study design. *Patients with uncontrolled acromegaly at screening (mean GH ≥1.0 μg/L and sex- and age-adjusted IGF-I >1.3 × ULN). FU, follow-up.